LEERINK PARTNERS analysts reiterated a Outperform rating on Sanofi (NASDAQ:SNY) on January 23, 2026.
Sanofi operates in the Healthcare sector. The stock currently trades at $45.77 with a market capitalization of $119.0B.
reiterateNASDAQ:SNY
LEERINK PARTNERS Reiterates Outperform Rating on Sanofi (SNY)
LEERINK PARTNERS analysts reiterated a Outperform rating on Sanofi (NASDAQ:SNY) on January 23, 2026. Sanofi operates in the Healthcare sector. The stock currently trades at $45.77…
